$LIDR
AEye, Inc. Stock $lidr

$lidr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000181864422000012 Filed on May 13, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$1.082M	$329.0K
YoY Change	228.88%	105.63%
Cost Of Revenue	$1.482M	$617.0K
YoY Change	140.19%	460.91%
Gross Profit	-$400.0K	-$288.0K
YoY Change	38.89%	-676.0%
Gross Profit Margin	-36.97%	-87.54%
Selling, General & Admin	$15.95M	$4.597M
YoY Change	246.88%	52.72%
% of Gross Profit
Research & Development	$8.576M	$5.836M
YoY Change	46.95%	28.55%
% of Gross Profit
Depreciation & Amortization	$208.0K	$245.0K
YoY Change	-15.1%
% of Gross Profit
Operating Expenses	$24.52M	$10.43M
YoY Change	135.04%	38.37%
Operating Profit	-$24.92M	-$10.72M
YoY Change	132.46%	43.14%
Interest Expense	$392.0K	-$788.0K
YoY Change	-149.75%	-161.56%
% of Operating Profit
Other Income/Expense, Net	$49.00K	-$788.0K
YoY Change	-106.22%
Pretax Income	-$24.87M	-$11.51M
YoY Change	116.12%	85.03%
Income Tax	$8.000K	$0.00
% Of Pretax Income
Net Earnings	-$24.88M	-$11.51M
YoY Change	116.19%
Net Earnings / Revenue	-2299.54%	-3498.18%
Basic Earnings Per Share	-$0.16	-$0.11
Diluted Earnings Per Share	-$0.16	-$0.11
COMMON SHARES
Basic Shares Outstanding	155.5M shares	101.4M shares
Diluted Shares Outstanding	155.5M shares	101.4M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.9M	$30.00K
YoY Change	479403.33%
Cash & Equivalents	$11.18M	$15.36M
Short-Term Investments	$132.7M
Other Short-Term Assets	$1.027M	$480.0K
YoY Change	113.96%
Inventory	$4.254M
Prepaid Expenses	$3.203M
Receivables	$292.0K
Other Receivables	$0.00
Total Short-Term Assets	$152.9M	$510.0K
YoY Change	29887.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.685M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.109M	$230.3M
YoY Change	-99.52%
Total Long-Term Assets	$24.91M	$230.3M
YoY Change	-89.18%
TOTAL ASSETS
Total Short-Term Assets	$152.9M	$510.0K
Total Long-Term Assets	$24.91M	$230.3M
Total Assets	$177.9M	$230.8M
YoY Change	-22.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.952M
YoY Change
Accrued Expenses	$8.995M	$380.0K
YoY Change	2267.11%
Deferred Revenue	$1.852M
YoY Change
Short-Term Debt	$0.00	$730.0K
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.80M	$1.130M
YoY Change	1032.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$485.0K	$11.04M
YoY Change	-95.61%
Total Long-Term Liabilities	$485.0K	$11.04M
YoY Change	-95.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.80M	$1.130M
Total Long-Term Liabilities	$485.0K	$11.04M
Total Liabilities	$30.61M	$12.17M
YoY Change	151.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$176.7M
YoY Change
Common Stock	$16.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$147.2M	-$28.04M
YoY Change
Total Liabilities & Shareholders Equity	$177.9M	$230.8M
YoY Change	-22.93%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$24.88M	-$11.51M
YoY Change	116.19%
Depreciation, Depletion And Amortization	$208.0K	$245.0K
YoY Change	-15.1%
Cash From Operating Activities	-$16.02M	-$8.814M
YoY Change	81.79%
INVESTING ACTIVITIES
Capital Expenditures	$774.0K	$121.0K
YoY Change	539.67%
Acquisitions
YoY Change
Other Investing Activities	$15.50M	$10.00K
YoY Change	154900.0%
Cash From Investing Activities	$14.73M	-$121.0K
YoY Change	-12270.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00	$333.0K
YoY Change	-100.0%
Cash From Financing Activities	-$1.709M	$7.797M
YoY Change	-121.92%
NET CHANGE
Cash From Operating Activities	-$16.02M	-$8.814M
Cash From Investing Activities	$14.73M	-$121.0K
Cash From Financing Activities	-$1.709M	$7.797M
Net Change In Cash	-$3.006M	-$1.138M
YoY Change	164.15%
FREE CASH FLOW
Cash From Operating Activities	-$16.02M	-$8.814M
Capital Expenditures	$774.0K	$121.0K
Free Cash Flow	-$16.80M	-$8.935M
YoY Change	87.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001818644
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	333-259554
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	AEye, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1827430
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Park Place
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94568
CY2022Q1	dei	City Area Code CityAreaCode	(925)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	400-4366
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	157354806	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11177000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14183000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	132674000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	149824000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	292000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4222000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	4254000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4085000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4541000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5051000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	152938000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	177365000	USD
CY2022Q1	us-gaap	Assets Assets	177850000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15968000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5685000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5129000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2150000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2150000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1109000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1509000	USD
CY2021Q4	us-gaap	Assets Assets	186153000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1952000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2542000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8995000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8739000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1852000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2287000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12799000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13568000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17323000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3032000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	485000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	786000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	30607000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	17386000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156364924	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156364924	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155137237	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155137237	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325350000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	320937000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1447000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-391000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-176676000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151795000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	147243000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	168767000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	177850000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	186153000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1082000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	329000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1482000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	617000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	-400000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	-288000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8576000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5836000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4616000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1587000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11330000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3010000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	24522000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	10433000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-24922000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10721000	USD
CY2022Q1	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	-32000	USD
CY2021Q1	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	-103000	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	424000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	3000	USD
CY2022Q1	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	343000	USD
CY2021Q1	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	688000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-788000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24881000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11509000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	155515093	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	155515093	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101362036	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101362036	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24881000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11509000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1056000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25937000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11509000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	168767000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5340000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	222000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1149000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1056000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24881000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	147243000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-18225000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1610000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	85000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11509000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-28039000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24881000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3930000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11509000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	208000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	245000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	317000	USD
CY2022Q1	lidr	Interest Expense Noncash InterestExpenseNoncash	0	USD
CY2021Q1	lidr	Interest Expense Noncash InterestExpenseNoncash	114000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	267000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2022Q1	lidr	Change In Fair Value Of Embedded Derivative And Warrant Liability ChangeInFairValueOfEmbeddedDerivativeAndWarrantLiability	-32000	USD
CY2021Q1	lidr	Change In Fair Value Of Embedded Derivative And Warrant Liability ChangeInFairValueOfEmbeddedDerivativeAndWarrantLiability	17000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5340000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1610000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	283000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-594000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-332000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-400000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2785000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	205000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	436000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	235000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-510000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-567000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2494000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-645000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	873000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-325000	USD
CY2021Q1	lidr	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-133000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-767000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	119000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16023000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8814000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	774000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121000	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	15500000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14726000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	222000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	85000	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8045000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	333000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1931000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1709000	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	143900000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include investments, embedded derivative and warrant liabilities, fair value of common stock, and stock-based compensation.
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5685000	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:0.12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased which mitigates risk.</span></div><div style="margin-bottom:0.12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivables are derived from customers located in the U.S., Europe, and Asia. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally does not require collateral.</span></div>The Company’s concentration of risk related to accounts receivable and accounts payable was determined by evaluating the number of customers and vendors accounting for 10% or more of accounts receivable (“AR”) and accounts payable (“AP”).
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q3	lidr	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	301000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	lidr	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	lidr	Class Of Warrant Or Right Period Exercisable ClassOfWarrantOrRightPeriodExercisable	P30D
CY2021Q3	lidr	Class Of Warrant Or Right Expiration Period ClassOfWarrantOrRightExpirationPeriod	P5Y
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	220000000	USD
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	640000	USD
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2021Q3	us-gaap	Recapitalization Costs RecapitalizationCosts	2198000	USD
CY2021Q3	lidr	Gross Proceeds From Reverse Recapitalization Transaction GrossProceedsFromReverseRecapitalizationTransaction	256811000	USD
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2021Q3	lidr	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	36811000	USD
CY2021Q3	lidr	Reverse Recapitalization Net ReverseRecapitalizationNet	204150000	USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154404302	shares
CY2021Q3	lidr	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	122509667	shares
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	586000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11177000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14183000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2150000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2150000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13327000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16333000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1810000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1544000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2432000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2447000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	94000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	4254000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4085000	USD
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	966000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1122000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3980000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3203000	USD
CY2022Q1	lidr	Demonstration Units Current DemonstrationUnitsCurrent	311000	USD
CY2021Q4	lidr	Demonstration Units Current DemonstrationUnitsCurrent	224000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1027000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	847000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4541000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5051000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	577000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	63000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7797000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3006000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1138000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16333000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16497000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13327000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15359000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	44000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	260000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	35000	USD
CY2022Q1	lidr	Tax Withholding For Share Based Payment Arrangement Incurred But Not Yet Paid TaxWithholdingForShareBasedPaymentArrangementIncurredButNotYetPaid	53000	USD
CY2021Q1	lidr	Tax Withholding For Share Based Payment Arrangement Incurred But Not Yet Paid TaxWithholdingForShareBasedPaymentArrangementIncurredButNotYetPaid	0	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16284000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15968000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2273000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17323000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	19596000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0531
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1745000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2342000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2412000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2484000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2559000	USD
CY2022Q1	lidr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	13752000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25294000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5698000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	19596000	USD
CY2022Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	473000	USD
CY2021Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	3637000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1713000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2331000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2342000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2412000	USD
CY2021Q1	lidr	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	4824000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	13622000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8097000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7333000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2412000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2204000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5685000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5129000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	208000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	245000	USD
CY2022Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	950000	USD
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1376000	USD
CY2022Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	159000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	133000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1109000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1509000	USD
CY2022Q1	lidr	Accrued Purchases And Other Current AccruedPurchasesAndOtherCurrent	2840000	USD
CY2021Q4	lidr	Accrued Purchases And Other Current AccruedPurchasesAndOtherCurrent	1947000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2273000	USD
CY2022Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1763000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3408000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1277000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	957000	USD
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	498000	USD
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1547000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	336000	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	275000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2021Q1	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	688000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	605000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8995000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8739000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	267000	USD
CY2022Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-336000	USD
CY2021Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	0	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7000	USD
CY2021Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
CY2022Q1	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	343000	USD
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156364924	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156364924	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	16383725	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24881000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11509000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	155515093	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101362036	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	155515093	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101362036	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50024185	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	52175241	shares
CY2022Q1	lidr	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	29238432	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	127345000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	656303	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.34
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	193018	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.54
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	lidr	Share Based Compensation Arrangement By Share Based Payment Award Options Repurchases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasesInPeriod	0	shares
CY2022Q1	lidr	Share Based Compensation Arrangements By Share Based Payment Award Options Repurchases In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRepurchasesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28389111	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.49
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	141445000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	28389111	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.49
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	141445000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	19321613	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.42
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	97483000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5340000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1610000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2918000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8360000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1082000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	329000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1082000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	329000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1852000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	299000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2151000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	660000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	767000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16000	USD
CY2022Q1	lidr	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	0	USD
CY2021Q1	lidr	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	135000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2151000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	779000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD

Files In Submission

Name	View Source	Status
0001818644-22-000012-index-headers.html	Edgar Link	pending
0001818644-22-000012-index.html	Edgar Link	pending
0001818644-22-000012.txt	Edgar Link	pending
0001818644-22-000012-xbrl.zip	Edgar Link	pending
exhibit311ceosection302cer.htm	Edgar Link	pending
exhibit312cfosection302cer.htm	Edgar Link	pending
exhibit321section906certif.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lidr-20220331.htm	Edgar Link	pending
lidr-20220331.xsd	Edgar Link	pending
lidr-20220331_cal.xml	Edgar Link	unprocessable
lidr-20220331_def.xml	Edgar Link	unprocessable
lidr-20220331_g1.jpg	Edgar Link	pending
lidr-20220331_htm.xml	Edgar Link	completed
lidr-20220331_lab.xml	Edgar Link	unprocessable
lidr-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIDR
AEye, Inc. Stock $lidr

2022 Q1 Form 10-Q Financial Statement

#000181864422000012 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIDR AEye, Inc. Stock $lidr

2022 Q1 Form 10-Q Financial Statement

#000181864422000012 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIDR
AEye, Inc. Stock $lidr